To validate the CRISPRi screen results, we selected three lncRNA genes DARS1-AS1, LINC00944, and RPPH1 that were among the top-ranked ones out of the 57 total hits (table S1) and do not yet have an established function in GBM for functional validation. The gene discussed is RPPH1; the disease is glioblastoma.